Practical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiation
Lung Cancer Manag
.
2020 Feb 6;9(1):LMT23.
doi: 10.2217/lmt-2020-0001.
Authors
Nikhil A Shukla
1
,
Nasser H Hanna
1
Affiliation
1
Division of Hematology/Oncology, Department of Medicine, Indiana University Melvin & Bren Simon Cancer Center, Indianapolis, IN 46202, USA.
PMID:
32256709
PMCID:
PMC7110574
DOI:
10.2217/lmt-2020-0001
No abstract available
Keywords:
checkpoint inhibitors; chemoradiation; lung cancer.
Publication types
Editorial